Amylin Pharma (Comparative Multiple Analysis)
Improve your investment analysis with by seeing the Amylin Pharma's Discounted Cash Flow analysis, Amylin Pharma's Warren Buffet analysis, and Amylin Pharma's Weighted Average Cost of Capital (WACC) Analysis.
Notes on the Comparative Multiple Analysis of Amylin Pharma
WikiWealth compares Amylin Pharma's revenue, EBITDA, and EBIT multiples to their peers in order to determine the appropriate fair valuation. Click in the top right corner to experiment with Amylin Pharma's comparative analysis.
Notes from the analysis:
1. WikiWealth uses quantitative measures to determine the multiple range for Amylin Pharma.
Helpful Information for Amylin Pharma's Analysis
How does this work? The Comparative Investment Analysis determines the value of Amylin Pharma by comparing Amylin Pharma financial ratios, prices, growth rates, margins, etc. to those of relevant peer groups.
Value Investing Importance? This method is widely used by investment professionals to determine the correct price of investments, especially initial public offerings (IPOs). It is one element of WikiWealth's three Wall Street approaches used to determine the correct fair value of Amylin Pharma.
Also, see the Amylin Pharma's buffett intrinsic valuation analysis for WikiWealth's attempt to replicate the investing formula's used by Warren Buffett and Amylin Pharma's valuation conclusion for a quick summary.